[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
\[18F\]FT8, a derivative of 1-(4-pyridyl)-4-piperazinyl arene (\[18F\]TPZA), exhibits high affinity for AL amyloid in myocardial tissue sections and shows no significant binding to transthyretin amyloid. By comparing its diagnostic performance against established clinical methods, including echocardiography, contrast-enhanced MRI, and relevant laboratory tests, this study aims to establish \[18F\]FT8 as the basis for a robust PET protocol for the direct visualization and differential diagnosis of AL amyloidosis . The study preimarily evaluates the safety and diagnostic efficacy of \[18F\]FT8 PET imaging in human subjects.
Epistemonikos ID: ecc178cbc52ddd443a202c870e032afaf894d691
First added on: Nov 19, 2025